Methanol → 6-(4-benzyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)-N-cyclopentyl-N-(3-hydroxypropyl)pyridine-3-sulfonamide

HRID 45252Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 45252
[CH2:1]([C:8]1[C:12](=[O:13])[N:11]([C:14]2[N:19]=[CH:18][C:17]([S:20]([N:23]([CH2:29][CH2:30][CH2:31][O:32]CC3C=CC=CC=3)[CH:24]3[CH2:28][CH2:27][CH2:26][CH2:25]3)(=[O:22])=[O:21])=[CH:16][CH:15]=2)[NH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.B(Br)(Br)Br.CO>C(Cl)Cl>[CH2:1]([C:8]1[C:12](=[O:13])[N:11]([C:14]2[N:19]=[CH:18][C:17]([S:20]([N:23]([CH:24]3[CH2:28][CH2:27][CH2:26][CH2:25]3)[CH2:29][CH2:30][CH2:31][OH:32])(=[O:21])=[O:22])=[CH:16][CH:15]=2)[NH:10][CH:9]=1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1

Komponenten

5

Versuchsvorschrift

To a solution of 150 mg (0.27 mmol) of 6-(4-benzyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)-N-[3-(benzyloxy)propyl]-N-cyclopentylpyridine-3-sulfonamide in 2 mL of DCM is added dropwise, at −78° C. under argon, 0.82 mL (0.82 mmol) of boron tribromide (1M in DCM). Stirring is continued for 1 hour at −78° C., and 2 mL of MeOH are then added at 0° C. The medium is taken up in 40 mL of DCM, washed successively with saturated NaHCO3 solution (30 mL) and brine (30 mL), dried over Na2SO4 and then concentrated under reduced pressure and purified by chromatography on a column of silica gel, eluting with a 9/1 DCM/MeOH mixture. 106 mg of 6-(4-benzyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)-N-cyclopentyl-N-(3-hydroxypropyl)pyridine-3-sulfonamide are thus obtained in the form of a powder.

Aufarbeitung

  1. washwashed successively with saturated NaHCO3 solution (30 mL) and brine (30 mL)
  2. dry with materialdried over Na2SO4
  3. concentrationconcentrated under reduced pressure
  4. custompurified by chromatography on a column of silica gel
  5. washeluting with a 9/1 DCM/MeOH mixture

Quellen und Nachweise

ORD-Eintrag
ord-524d5b8a89904105974cb1f5b6ff1260
Quelldatensatz
uspto-grants-2013_09
Patentnummer
US08541455B2

Notizen zur Reaktion

Wird geladen…